Abstract
To investigate whether isoproterenol (Iso) could suppress the initiation of repetitive atrial firing (RAF), we investigated its effect on RAF in comparison with that of disopyramide (Diso). Extrastimuli at a basic cycle length of 500 ms were delivered from the high right atrium in 49 patients who received an intravenous infusion of Iso (0.01 μg/kg per min) and in 39 patients given intravenous Diso (2 mg/kg per 10 min). Induction of RAF, the atrial effective refractory period (A-ERP), and the maximum conduction delay (MCD) were measured. Iso abolished the induction of RAF in 13 19 (68%) patients, while Diso did so in 13 22 (59%) patients. Thirty-four of the 41 patients with RAF in the base-line study had an A-ERP <250 ms and an MCD >40 ms. Iso significantly decreased the A-ERP from 205 ± 26 to 194 ± 23 ms ( P < 0.01) and significantly decreased the MCD from 67 ± 24 to 39 ± 16 ms ( P < 0.0001) in 19 patients with RAF. On the other hand, Diso significantly increased the A-ERP from 203 ± 31 to 235 ± 36 ms ( P < 0.0001), and significantly diminished the MCD from 68 ± 31 to 55 ± 30 ms ( P < 0.01) in 22 patients with RAF. In patients with new RAF ( n = 7) or re-induced RAF ( n = 14) during Iso or after Diso, the MCD was more than 40 ms. Our results suggest that there are two different modes of RAF suppression, i.e. shortening or lengthening of the A-ERP. Thus, suppression of RAF is probably due to a reduction of conduction delay, with Iso accelerating conduction and Diso diminishing conduction delay as a result of prolongation of the A-ERP.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.